Cholesterol catabolism as a therapeutic target in Mycobacterium tuberculosis.

No abstract is available for this paper.

• Publication year

  2011

• Venue

  Trends in Microbiology

• Publication date

  2011-11-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1016/j.tim.2011.07.009PMID 21924910PMCID PMC3205253
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Expression and characterization of Mycobacterium tuberculosis CYP144: common themes and lessons learned in the M. tuberculosis P450 enzyme family.

  2011cited by this paper
• Structural control of cytochrome P450-catalyzed ω-hydroxylation.

  2011cited by this paper
• FadD19 of Rhodococcus rhodochrous DSM43269, a Steroid-Coenzyme A Ligase Essential for Degradation of C-24 Branched Sterol Side Chains

  2011cited by this paper
• Reverse type I inhibitor of Mycobacterium tuberculosis CYP125A1.

  2011cited by this paper
• Inhibition of the M. tuberculosis 3β-hydroxysteroid dehydrogenase by azasteroids.

  2011cited by this paper
• Initial step in the catabolism of cholesterol by Mycobacterium smegmatis mc2 155.

  2011cited by this paper
• Cholesterol Is Not an Essential Source of Nutrition for Mycobacterium tuberculosis during Infection

  2011cited by this paper
• Caseation of human tuberculosis granulomas correlates with elevated host lipid metabolism

  2010cited by this paper
• Cholesterol utilization in mycobacteria is controlled by two TetR-type transcriptional regulators: kstR and kstR2

  2010cited by this paper
• Structure and function of Mycobacterium tuberculosis CYP142 Structural and biochemical characterization of Mycobacterium tuberculosis CYP142: Evidence for multiple cholesterol 27-hydroxylase activities in a human pathogen

  2010cited by this paper
• A Flavin-dependent Monooxygenase from Mycobacterium tuberculosis Involved in Cholesterol Catabolism*

  2010cited by this paper
• Mycobacterium tuberculosis CYP125A1, a steroid C27 monooxygenase that detoxifies intracellularly generated cholest‐4‐en‐3‐one

  2010influential reference
• 3‐Ketosteroid 9α‐hydroxylase is an essential factor in the pathogenesis of Mycobacterium tuberculosis

  2010cited by this paper
• Functional Redundancy of Steroid C26-monooxygenase Activity in Mycobacterium tuberculosis Revealed by Biochemical and Genetic Analyses*

  2010influential reference
• Structural and Biochemical Characterization of Mycobacterium tuberculosis CYP142

  2010cited by this paper
• Studies of a Ring-Cleaving Dioxygenase Illuminate the Role of Cholesterol Metabolism in the Pathogenesis of Mycobacterium tuberculosis

  2009cited by this paper
• Characterization of a Carbon-Carbon Hydrolase from Mycobacterium tuberculosis Involved in Cholesterol Metabolism*

  2009cited by this paper
• The Role of Scavenger Receptor B1 in Infection with Mycobacterium tuberculosis in a Murine Model

  2009cited by this paper
• Mycobacterium tuberculosis Is Able To Accumulate and Utilize Cholesterol

  2009cited by this paper
• igr Genes and Mycobacterium tuberculosis Cholesterol Metabolism

  2009cited by this paper
• Mycobacterial Cytochrome P450 125 (Cyp125) Catalyzes the Terminal Hydroxylation of C27 Steroids*

  2009cited by this paper
• Characterization of 3-Ketosteroid 9α-Hydroxylase, a Rieske Oxygenase in the Cholesterol Degradation Pathway of Mycobacterium tuberculosis*

  2009cited by this paper
• Cytochrome P450 125 (CYP125) catalyses C26-hydroxylation to initiate sterol side-chain degradation in Rhodococcus jostii RHA1.

  2009cited by this paper
• A Thiolase of Mycobacterium tuberculosis Is Required for Virulence and Production of Androstenedione and Androstadienedione from Cholesterol

  2009influential reference
• Cholesterol metabolism increases the metabolic pool of propionate in Mycobacterium tuberculosis.

  2009cited by this paper
• The Structure of Mycobacterium tuberculosis CYP125

  2009cited by this paper
• Biochemical and structural characterization of CYP124: A methyl-branched lipid ω-hydroxylase from Mycobacterium tuberculosis

  2009cited by this paper
• Mycobacterium tuberculosis Entry into Mast Cells Through Cholesterol‐rich Membrane Microdomains

  2009cited by this paper
• The Actinobacterial mce4 Locus Encodes a Steroid Transporter*

  2008cited by this paper
• Mycobacterial persistence requires the utilization of host cholesterol

  2008influential reference
• Characterization of a Second Rhodococcus erythropolis SQ1 3-Ketosteroid 9α-Hydroxylase Activity Comprising a Terminal Oxygenase Homologue, KshA2, Active with Oxygenase-Reductase Component KshB

  2008cited by this paper
• Functional Characterization of a Vitamin B12-Dependent Methylmalonyl Pathway in Mycobacterium tuberculosis: Implications for Propionate Metabolism during Growth on Fatty Acids

  2008cited by this paper
• Hypercholesterolemia Impairs Immunity to Tuberculosis

  2008cited by this paper
• Mycobacterium tuberculosis CYP130

  2008cited by this paper
• 3-Keto-5alpha-steroid Delta(1)-dehydrogenase from Rhodococcus erythropolis SQ1 and its orthologue in Mycobacterium tuberculosis H37Rv are highly specific enzymes that function in cholesterol catabolism.

  2008influential reference
• Characterization of Active Site Structure in CYP121

  2008cited by this paper
• University of Groningen Characterization of a Second Rhodococcus erythropolis SQ1 3-Ketosteroid 9 alpha- Hydroxylase Activity Comprising a Terminal Oxygenase Homologue, KshA2, Active with Oxygenase-Reductase Component KshB

  2008cited by this paper
• Identification of Mycobacterial genes that alter growth and pathology in macrophages and in mice.

  2007cited by this paper
• Lanosterol biosynthesis in the prokaryote Methylococcus capsulatus: insight into the evolution of sterol biosynthesis.

  2007cited by this paper
• Rv1106c from Mycobacterium tuberculosis is a 3beta-hydroxysteroid dehydrogenase.

  2007cited by this paper
• Rv1106c from Mycobacterium tuberculosis is a 3β-hydroxysteroid dehydrogenase

  2007cited by this paper
• A highly conserved transcriptional repressor controls a large regulon involved in lipid degradation in Mycobacterium smegmatis and Mycobacterium tuberculosis

  2007cited by this paper
• Mycobacterium Tuberculosis Cyp130:Crystal Mycobacterium Tuberculosis Cyp130: Crystal Structure, Biophysical Characterization, and Interactions with Antifungal Azole Drugs.

  2007cited by this paper
• A gene cluster encoding cholesterol catabolism in a soil actinomycete provides insight into Mycobacterium tuberculosis survival in macrophages

  2007influential reference
• Cholesterol oxidase is required for virulence of Mycobacterium tuberculosis.

  2007cited by this paper
• The potential of azole antifungals against latent/persistent tuberculosis.

  2006cited by this paper
• Generation of Useful Insertionally Blocked Sterol Degradation Pathway Mutants of Fast-Growing Mycobacteria and Cloning, Characterization, and Expression of the Terminal Oxygenase of the 3-Ketosteroid 9α-Hydroxylase in Mycobacterium smegmatis mc2155

  2006cited by this paper
• Antimycobacterial activity of econazole against multidrug-resistant strains of Mycobacterium tuberculosis.

  2006cited by this paper
• Mycobacterium tuberculosis isocitrate lyases 1 and 2 are jointly required for in vivo growth and virulence

  2005cited by this paper
• The Trojan horse: survival tactics of pathogenic mycobacteria in macrophages.

  2005cited by this paper
• Genome-wide requirements for Mycobacterium tuberculosis adaptation and survival in macrophages.

  2005influential reference
• Sterol structure determines miscibility versus melting transitions in lipid vesicles.

  2005cited by this paper
• Interplay between mycobacteria and host signalling pathways

  2004cited by this paper
• Transcriptional Adaptation of Mycobacterium tuberculosis within Macrophages

  2003cited by this paper
• Phylogenetic and biochemical evidence for sterol synthesis in the bacterium Gemmata obscuriglobus

  2003cited by this paper
• Genetic requirements for mycobacterial survival during infection

  2003cited by this paper
• Molecular genetics of Mycobacterium tuberculosis pathogenesis.

  2003cited by this paper
• Expression, purification and spectroscopic characterization of the cytochrome P450 CYP121 from Mycobacterium tuberculosis.

  2002cited by this paper
• Sterol 14alpha-demethylase activity in Streptomyces coelicolor A3(2) is associated with an unusual member of the CYP51 gene family.

  2002cited by this paper
• Molecular and functional characterization of the kstD2 gene of Rhodococcus erythropolis SQ1 encoding a second 3-ketosteroid Delta(1)-dehydrogenase isoenzyme.

  2002cited by this paper
• Azole antifungals are potent inhibitors of cytochrome P450 mono-oxygenases and bacterial growth in mycobacteria and streptomycetes.

  2002cited by this paper
• Unmarked gene deletion mutagenesis of kstD, encoding 3-ketosteroid Delta1-dehydrogenase, in Rhodococcus erythropolis SQ1 using sacB as counter-selectable marker.

  2001cited by this paper
• Cholesterol is accumulated by mycobacteria but its degradation is limited to non-pathogenic fast-growing mycobacteria.

  2000cited by this paper
• Nonopsonic Phagocytosis of Mycobacterium kansasii by Human Neutrophils Depends on Cholesterol and Is Mediated by CR3 Associated with Glycosylphosphatidylinositol-Anchored Proteins1

  2000cited by this paper
• Essential role for cholesterol in entry of mycobacteria into macrophages.

  2000cited by this paper
• The effect of sterol structure on membrane lipid domains reveals how cholesterol can induce lipid domain formation.

  2000cited by this paper
• Characterization and catalytic properties of the sterol 14alpha-demethylase from Mycobacterium tuberculosis.

  1999cited by this paper
• Deciphering the biology of Mycobacterium tuberculosis from the complete genome sequence

  1998cited by this paper
• Erratum: Deciphering the biology of Mycobacterium tuberculosis from the complete genome sequence

  1998cited by this paper
• beta-oxidation of fatty acids in mitochondria, peroxisomes, and bacteria: a century of continued progress.

  1995cited by this paper
• 6-Azasteroids: structure-activity relationships for inhibition of type 1 and 2 human 5 alpha-reductase and human adrenal 3 beta-hydroxy-delta 5-steroid dehydrogenase/3-keto-delta 5-steroid isomerase.

  1994cited by this paper
• 6-Azasteroids: potent dual inhibitors of human type 1 and 2 steroid 5 alpha-reductase.

  1993cited by this paper
• Spectral properties of 3-ketosteroid-delta 1-dehydrogenase from Nocardia corallina.

  1990cited by this paper
• Spectral properties of 3-ketosteroid-Δ1-dehydrogenase from Nocardia corallina

  1990cited by this paper
• Purification and characterization of 3-ketosteroid-delta 1-dehydrogenase from Nocardia corallina.

  1990cited by this paper
• Acyl coenzyme A:cholesterol acyl transferase in macrophages utilizes a cellular pool of cholesterol oxidase-accessible cholesterol as substrate.

  1988cited by this paper
• BIOCHEMICAL DIFFERENTIATION OF MYCOBACTERIUM TUBERCULOSIS GROWN IN VIVO AND IN VITRO

  1956cited by this paper
• Structural Biology and Crystallization Communications Crystallization and Preliminary X-ray Diffraction Analysis of X-amino Acid:pyruvate Transaminase from Chromobacterium Violaceum

  year unknowncited by this paper

• Dynamic remodeling of the pulmonary microenvironment driven by Mycobacterium tuberculosis infection: Mechanisms and implications.

  2026cites this paper
• Diverse Ligands for Mycobacterial CYP124 Identified from Plant and Marine Compounds

  2026cites this paper
• Phagosomal escape and sabotage: The role of ESX-1 and PDIMs in Mycobacterium tuberculosis pathogenesis

  2025cites this paper
• Comprehensive review of steroid metabolism in Comamonas testosteroni TA441 with insights from other aerobic steroid-degrading bacteria.

  2025cites this paper
• Mycobacteriumabscessus CYP123 is a steroid hydroxylase with an implication in host infection

  2025cites this paper
• Comparative in silico analysis of mce operons across Mycobacteriaceae and Nocardiaceae: Insights into genetic arrangements and regulatory mechanisms

  2025cites this paper
• Insight into the structure and interactions of the M. tuberculosis Mce-associated membrane proteins Mam1A-1D

  2025cites this paper
• Pharmacologic properties and inhibitory activity of 6-azasteroids against Mycobacterium leprae in vivo and in vitro

  2025cites this paper
• Fragment-Based Development of Small Molecule Inhibitors Targeting Mycobacterium tuberculosis Cholesterol Metabolism

  2025cites this paper
• AEBS inhibition in macrophages: Augmenting reality for SERMs repurposing against infections.

  2024cites this paper
• Cell Membrane Cholesterol and Regulation of Cellular Processes: New and the Same Old Thing

  2024cites this paper
• Mycobacterium tuberculosis Suppresses Inflammatory Responses in Host through Its Cholesterol Metabolites.

  2024cites this paper
• Fragment-based development of small molecule inhibitors targeting Mycobacterium tuberculosis cholesterol metabolism

  2024cites this paper
• The Difference in Average Cholesterol in the BMI Group of TB-DM Sufferers at Dr Soetomo General Academic Hospital Surabaya

  2024cites this paper
• Synthesis of steroidal inhibitors for Mycobacterium tuberculosis.

  2024cites this paper
• Effects of Bacillus Calmette-Guérin on immunometabolism, microbiome and liver diseases

  2023cites this paper
• Proximity‐dependent biotin identification links cholesterol catabolism with branched‐chain amino acid degradation in Mycobacterium smegmatis

  2023cites this paper
• Recent advances in Fragment-based strategies against tuberculosis.

  2023cites this paper
• Unravelling and engineering an operon involved in the side-chain degradation of sterols in Mycolicibacterium neoaurum for the production of steroid synthons

  2023cites this paper
• Targeting Mycobacterium tuberculosis iron-scavenging tools: a recent update on siderophores inhibitors.

  2023cites this paper
• The oxidation of steroid derivatives by the CYP125A6 and CYP125A7 enzymes from Mycobacterium marinum.

  2023cites this paper
• Deciphering drug discovery and microbial pathogenesis research in tuberculosis during the two decades of postgenomic era using entity mining approach

  2023cites this paper
• Green Manufacturing of Steroids via Mycolicbacteria: Current Status and Development Trends

  2023cites this paper
• Cyclic AMP-Mediated Inhibition of Cholesterol Catabolism in Mycobacterium tuberculosis by the Novel Drug Candidate GSK2556286

  2023cites this paper
• The catalytic activity and structure of the lipid metabolizing CYP124 cytochrome P450 enzyme from Mycobacterium marinum.

  2023cites this paper
• New Insights into the Modification of the Non-Core Metabolic Pathway of Steroids in Mycolicibacterium and the Application of Fermentation Biotechnology in C-19 Steroid Production

  2023cites this paper
• Nyctanthes arbor-tristis L.: Perspective of phytochemical-based inhibition of fatty acid biosynthesis in Mycobacterium tuberculosis

  2022cites this paper
• Clinical strains of Mycobacterium tuberculosis exhibit differential lipid metabolism-associated transcriptome changes in in vitro cholesterol and infection models

  2022cites this paper
• Combined enhancement of the propionyl-CoA metabolic pathway for efficient androstenedione production in Mycolicibacterium neoaurum

  2022influential citation
• Construction of automated high-throughput screening method for finding efficient 3-ketosteroid 1,2-dehydrogenating strains

  2022cites this paper
• Direct capture, inhibition and crystal structure of HsaD (Rv3569c) from M. tuberculosis

  2022cites this paper
• The unusual convergence of steroid catabolic pathways in Mycobacterium abscessus

  2022cites this paper
• Roles of cysteine in the structure and metabolic function of Mycobacterium tuberculosis CYP142A1

  2022cites this paper
• The Lack of the TetR-Like Repressor Gene BCG_2177c (Rv2160A) May Help Mycobacteria Overcome Intracellular Redox Stress and Survive Longer Inside Macrophages When Surrounded by a Lipid Environment

  2022influential citation
• Unraveling novel roles of the Mycobacterium tuberculosis transcription factor Rv0081 in regulation of the nucleoid‐associated proteins Lsr2 and EspR, cholesterol utilization, and subversion of lysosomal trafficking in macrophages

  2022cites this paper
• Dissecting the Mycobacterium bovis BCG Response to Macrophage Infection to Help Prioritize Targets for Anti-Tuberculosis Drug and Vaccine Discovery

  2022cites this paper
• Phenotypic and genomic hallmarks of a novel, potentially pathogenic rapidly growing Mycobacterium species related to the Mycobacterium fortuitum complex

  2021cites this paper
• Further Studies on the 3-Ketosteroid 9α-Hydroxylase of Rhodococcus ruber Chol-4, a Rieske Oxygenase of the Steroid Degradation Pathway

  2021cites this paper
• GlnR‐mediated regulation of KstR controls cholesterol catabolism in Mycobacterium smegmatis

  2021cites this paper
• Interconnection of the mycobacterial heparin-binding hemagglutinin with cholesterol degradation and heme/iron pathways identified by proximity-dependent biotin identification in Mycobacterium smegmatis.

  2021cites this paper
• Application of microbial 3-ketosteroid Δ1-dehydrogenases in biotechnology.

  2021cites this paper
• Applications of Transcriptomics and Proteomics for Understanding Dormancy and Resuscitation in Mycobacterium tuberculosis

  2021cites this paper
• Enhancing production of 9α-hydroxy-androst-4-ene-3,17-dione (9-OHAD) from phytosterols by metabolic pathway engineering of mycobacteria

  2021cites this paper
• Mycolicibacterium cell factory for the production of steroid-based drug intermediates.

  2021cites this paper
• Pseudomonas aeruginosa cytochrome P450 CYP168A1 is a fatty acid hydroxylase that metabolizes arachidonic acid to the vasodilator 19-HETE

  2021cites this paper
• Developments in the Synthesis of Mycobacterial Phenolic Glycolipids

  2021cites this paper
• Synthesis and interaction of terminal unsaturated chemical probes with Mycobacterium tuberculosis CYP124A1.

  2021cites this paper
• Cross protection study in feline hemoplasmas

  2020cites this paper
• Lineage-specific differences in lipid metabolism and its impact on clinical strains of Mycobacterium tuberculosis.

  2020cites this paper
• Anti-tuberculous Effects of Statin Therapy: A Review of Literature

  2020cites this paper
• Metabolic fate of human immunoactive sterols in Mycobacterium tuberculosis

  2020cites this paper
• Determination of in vitro and in vivo immune response to recombinant cholesterol oxidase from Mycobacterium tuberculosis.

  2020cites this paper
• Cholesterol Review: A Metabolically Important Molecule.

  2020cites this paper
• Serum proteins TGFBI, PCSK9, and CCL14 are potential biomarkers for different traditional Chinese medicine syndromes of multidrug‐resistant tuberculosis

  2020cites this paper
• Prevalence, Types and Treatment of Tuberculosis: A Review

  2020cites this paper
• A Key Glycine in Bacterial Steroid-Degrading Acyl-CoA Dehydrogenases Allows Flavin-Ring Repositioning and Modulates Substrate Side Chain Specificity.

  2020cites this paper
• Modulation of the Cholesterol-Dependent Activity of Macrophages IC-21 by CRAC Peptides with Substituted Motif-Forming Amino Acids

  2020cites this paper
• Cholesterol Metabolism: As a Promising Target Candidate for Tuberculosis Treatment by Nanomedicine

  2020cites this paper
• Mycobacterium tuberculosis and myeloid-derived suppressor cells: Insights into caveolin rich lipid rafts

  2020cites this paper
• Dynamic Characterization of Protein and Posttranslational Modification Levels in Mycobacterial Cholesterol Catabolism

  2020cites this paper
• Steroids as Environmental Compounds Recalcitrant to Degradation: Genetic Mechanisms of Bacterial Biodegradation Pathways

  2019cites this paper
• The steroid side-chain–cleaving aldolase Ltp2–ChsH2DUF35 is a thiolase superfamily member with a radically repurposed active site

  2019cites this paper
• Effects of a nonionic surfactant TX-40 on 9α-hydroxyandrost-4-ene-3,17-dione biosynthesis and physiological properties of Mycobacterium sp. LY-1

  2019cites this paper
• Mycobacterium tuberculosis Requires Cholesterol Oxidase to Disrupt TLR2 Signalling in Human Macrophages

  2019cites this paper
• Modeling Host-Pathogen Interaction to Elucidate the Metabolic Drug Response of Intracellular Mycobacterium tuberculosis

  2019cites this paper
• Microenvironment of Mycobacterium smegmatis Culture to Induce Cholesterol Consumption Does Cell Wall Remodeling and Enables the Formation of Granuloma-Like Structures

  2019cites this paper
• Design, synthesis, and antimycobacterial activity of novel ciprofloxacin derivatives

  2019cites this paper
• Biochemical characterization of acyl-coenzyme A synthetases involved in mycobacterial steroid side-chain catabolism and molecular design: synthesis of an anti-mycobacterial agent

  2019cites this paper
• Advances in Cardiovascular Disease Lipid Research Can Provide Novel Insights Into Mycobacterial Pathogenesis

  2019cites this paper
• The role and mechanism of microbial 3-ketosteroid Δ1-dehydrogenases in steroid breakdown.

  2019cites this paper
• Development of a Synthetic 3-ketosteroid Δ1-dehydrogenase for the Generation of a Novel Catabolic Pathway Enabling Cholesterol Degradation in Human Cells

  2019cites this paper
• Topical Delivery of Artemisone, Clofazimine and Decoquinate Encapsulated in Vesicles and Their In vitro Efficacy Against Mycobacterium tuberculosis

  2019cites this paper
• Characterization of Two New Multidrug-Resistant Strains of Mycobacterium smegmatis: Tools for Routine In Vitro Screening of Novel Anti-Mycobacterial Agents

  2019cites this paper
• Identification of steroid C27 monooxygenase isoenzymes involved in sterol catabolism and stepwise pathway engineering of Mycobacterium neoaurum for improved androst-1,4-diene-3,17-dione production

  2019cites this paper
• The Nitrogen Regulator GlnR Directly Controls Transcription of the prpDBC Operon Involved in Methylcitrate Cycle in Mycobacterium smegmatis

  2019cites this paper
• Comprehensive Comparative Analysis of Cholesterol Catabolic Genes/Proteins in Mycobacterial Species

  2019influential citation
• Structural and functional insight into the Mycobacterium tuberculosis protein PrpR reveals a novel type of transcription factor

  2019cites this paper
• Modulation of Cholesterol-Dependent Activity of Macrophages IC-21 by a Peptide Containing Two CRAC-Motifs from Protein M1 of Influenza Virus

  2019cites this paper
• Whole genome sequencing analysis of a dexamethasone-degrading Burkholderia strain CQ001

  2019cites this paper
• Aerobic catabolism of sterols by microorganisms: key enzymes that open the 3-ketosteroid nucleus.

  2019cites this paper
• Nicotinamide and Demographic and Disease transitions: Moderation is Best

  2019cites this paper
• Integrated Transcriptome and Proteome Studies Reveal the Underlying Mechanisms for Sterol Catabolism and Steroid Production in Mycobacterium neoaurum.

  2018cites this paper
• Amphipathic CRAC-Containing Peptides Derived from the Influenza Virus A M1 Protein Modulate Cholesterol-Dependent Activity of Cultured IC-21 Macrophages

  2018cites this paper
• Designing novel inhibitors against Mycobacterium tuberculosis FadA5 (acetyl-CoA acetyltransferase) by virtual screening of known anti-tuberculosis (bioactive) compounds

  2018cites this paper
• Bacterial CYP154C8 catalyzes carbon‐carbon bond cleavage in steroids

  2018cites this paper
• Topical delivery of clofazimine, artemisone and decoquinate utilizing vesicles as carrier system

  2018cites this paper
• Cholesterol 7- alpha hydroxylase gene ( CYP7A1 ) promoter polymorphism rs3808607 as a risk factor for pulmonary tuberculosis in Egypt

  2018cites this paper
• Acquired low cholesterol: diagnosis and relevance to safety of low LDL therapeutic targets

  2018cites this paper
• Mechanism-based inhibition of HsaD: a C-C bond hydrolase essential for survival of Mycobacterium tuberculosis in macrophage. FEMS (1),

  2018cites this paper
• Preliminary Evaluation of Artemisinin–Cholesterol Conjugates as Potential Drugs for the Treatment of Intractable Forms of Malaria and Tuberculosis

  2018cites this paper
• Mycobacterium tuberculosis and lipids: Insights into molecular mechanisms from persistence to virulence

  2018cites this paper
• System-wide coordinates of higher order functions in host-pathogen environment upon Mycobacterium tuberculosis infection

  2018cites this paper
• PDIM and SL1 accumulation in Mycobacterium tuberculosis is associated with mce4A expression.

  2018cites this paper
• Two parallel pathways implement robust propionate catabolism and detoxification in mycobacteria

  2018cites this paper
• The anaplerotic node is essential for the intracellular survival of Mycobacterium tuberculosis

  2018cites this paper
• Steroid- CoA Ligases, FadD17A1 and FadD19A1, and Their Role in Cholesterol Side-Chain Degradation in Mycobacterium tuberculosis

  2018cites this paper
• Potential drug targets in the Mycobacterium tuberculosis cytochrome P450 system.

  2018cites this paper
• Anti-tuberculosis therapy: Urgency for new drugs and integrative approach

  2018cites this paper
• Nitrogen regulator GlnR directly controls transcription of prpDBC operon involved in methylcitrate cycle in Mycobacterium smegmatis

  2018cites this paper
• Overview of the Development of DprE1 Inhibitors for Combating the Menace of Tuberculosis.

  2018cites this paper